207 related articles for article (PubMed ID: 21611034)
1. Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI.
Lodhia J; Mandarano G; Ferris Nj; Eu P; Cowell S
Biomed Imaging Interv J; 2010; 6(2):e12. PubMed ID: 21611034
[TBL] [Abstract][Full Text] [Related]
2. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
3. Superparamagnetic Iron Oxide Nanoparticles-Current and Prospective Medical Applications.
Dulińska-Litewka J; Łazarczyk A; Hałubiec P; Szafrański O; Karnas K; Karewicz A
Materials (Basel); 2019 Feb; 12(4):. PubMed ID: 30791358
[TBL] [Abstract][Full Text] [Related]
4. A new class of cubic SPIONs as a dual-mode T1 and T2 contrast agent for MRI.
Alipour A; Soran-Erdem Z; Utkur M; Sharma VK; Algin O; Saritas EU; Demir HV
Magn Reson Imaging; 2018 Jun; 49():16-24. PubMed ID: 28958878
[TBL] [Abstract][Full Text] [Related]
5. Clustering superparamagnetic iron oxide nanoparticles produces organ-targeted high-contrast magnetic resonance images.
Hobson NJ; Weng X; Siow B; Veiga C; Ashford M; Thanh NT; Schätzlein AG; Uchegbu IF
Nanomedicine (Lond); 2019 May; 14(9):1135-1152. PubMed ID: 31050589
[No Abstract] [Full Text] [Related]
6. Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells.
Kumar M; Singh G; Arora V; Mewar S; Sharma U; Jagannathan NR; Sapra S; Dinda AK; Kharbanda S; Singh H
Int J Nanomedicine; 2012; 7():3503-16. PubMed ID: 22848174
[TBL] [Abstract][Full Text] [Related]
7. Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.
Neuwelt A; Sidhu N; Hu CA; Mlady G; Eberhardt SC; Sillerud LO
AJR Am J Roentgenol; 2015 Mar; 204(3):W302-13. PubMed ID: 25714316
[TBL] [Abstract][Full Text] [Related]
8. Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
Kievit FM; Zhang M
Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865
[TBL] [Abstract][Full Text] [Related]
9. 2-Deoxy-D-Glucose Modified Magnetic Nanoparticles with Dual Functional Properties: Nanothermotherapy and Magnetic Resonance Imaging.
Zhao L; Zheng Y; Yan H; Xie W; Sun X; Li N; Tang J
J Nanosci Nanotechnol; 2016 Mar; 16(3):2401-7. PubMed ID: 27455648
[TBL] [Abstract][Full Text] [Related]
10. Accumulation and Toxicity of Superparamagnetic Iron Oxide Nanoparticles in Cells and Experimental Animals.
Jarockyte G; Daugelaite E; Stasys M; Statkute U; Poderys V; Tseng TC; Hsu SH; Karabanovas V; Rotomskis R
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548152
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody-conjugated superparamagnetic iron oxide nanoparticles for imaging of epidermal growth factor receptor-targeted cells and gliomas.
Mu K; Zhang S; Ai T; Jiang J; Yao Y; Jiang L; Zhou Q; Xiang H; Zhu Y; Yang X; Zhu W
Mol Imaging; 2015; 14():. PubMed ID: 26044549
[TBL] [Abstract][Full Text] [Related]
13. Co-precipitation of DEAE-dextran coated SPIONs: how synthesis conditions affect particle properties, stem cell labelling and MR contrast.
Barrow M; Taylor A; García Carrión J; Mandal P; Park BK; Poptani H; Murray P; Rosseinsky MJ; Adams DJ
Contrast Media Mol Imaging; 2016 Sep; 11(5):362-370. PubMed ID: 27358113
[TBL] [Abstract][Full Text] [Related]
14. LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases.
Leuschner C; Kumar CS; Hansel W; Soboyejo W; Zhou J; Hormes J
Breast Cancer Res Treat; 2006 Sep; 99(2):163-76. PubMed ID: 16752077
[TBL] [Abstract][Full Text] [Related]
15. New Frontiers in Molecular Imaging with Superparamagnetic Iron Oxide Nanoparticles (SPIONs): Efficacy, Toxicity, and Future Applications.
Frantellizzi V; Conte M; Pontico M; Pani A; Pani R; De Vincentis G
Nucl Med Mol Imaging; 2020 Apr; 54(2):65-80. PubMed ID: 32377258
[TBL] [Abstract][Full Text] [Related]
16. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
[TBL] [Abstract][Full Text] [Related]
17. One-pot synthesis of water-soluble superparamagnetic iron oxide nanoparticles and their MRI contrast effects in the mouse brains.
Wang J; Zhang B; Wang L; Wang M; Gao F
Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():416-23. PubMed ID: 25579942
[TBL] [Abstract][Full Text] [Related]
18. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
[TBL] [Abstract][Full Text] [Related]
19. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy.
Thomas RG; Moon MJ; Lee H; Sasikala AR; Kim CS; Park IK; Jeong YY
Carbohydr Polym; 2015 Oct; 131():439-46. PubMed ID: 26256205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
